Archives

Wilmot began its nurse navigator program in 2017 with a goal to reduce the time-to-treatment interval and thereby improve patient outcomes. So far - it's working.

The drug ibrutinib is a highly effective treatment for people with chronic lymphocytic leukemia (CLL), but a new Wilmot Cancer Institute study shows that weight gain, as a drug side effect, should be ...

Patients with bone and joint conditions could receive treatment at one of the most comprehensive centers for orthopaedic surgery and outpatient care in the United States upon completion of a medical ...

The short answer is yes, said Eugene Storozynsky, M.D., Ph.D., who specializes in heart complications from cancer. He directs the Cardio-Oncology clinic associated with UR Medicine’s Wilmot Cancer ...

A pacemaker-like device restored heart function in a group of cancer survivors — mostly women with breast cancer — who had suffered from heart failure as a result of chemotherapy, a study in the ...

Glioblastoma

As lung injuries from vaping continue to rise across the United States, Rochester physicians and New York health leaders developed a new tool to assist in the diagnosis and treatment of e-cigarette, ...

A Wilmot Cancer Institute-led study in JAMA Oncology shows that when physicians fully appreciate the concerns of older adults with cancer, such as function and forgetfulness, it elevates patient care ...

Every August, Dr. Elizabeth Murray gets lots of questions about Back 2 School safety. So this year, she decided to turn the tables. Watch as she ambushes several local reporters to see what THEY know ...

Sharon Elad, DMD, MSc, professor and chair, Oral Medicine at Eastman Institute for Oral Health, was awarded the 2019 Outstanding Study Group Leader by the Multinational Association of Supportive Care ...